Evaluation of coronary heart disease risk prediction based on simple physical examination parameters by machine learning model: a retrospective cohort model development and validation study - Report - MDSpire

Evaluation of coronary heart disease risk prediction based on simple physical examination parameters by machine learning model: a retrospective cohort model development and validation study

  • By

  • Hui Xiong

  • Xiang Cao

  • Xiao Han

  • Jia-Xing Zhang

  • Jia-Rui Zhuang

  • Shuai He

  • Min Zhu

  • Ji Li

  • Wei Qin

  • April 30, 2026

  • 0 min

Share

Clinical Report: Development and Validation of a Machine Learning Model for Predicting Coronary Heart Disease Risk

Overview

This study developed and validated a machine learning model for predicting coronary heart disease (CHD) risk using routine clinical indicators. The model demonstrated strong performance in both internal and external validation cohorts, highlighting its potential as a clinically interpretable tool for cardiovascular risk assessment.

Background

Coronary heart disease (CHD) is a leading cause of mortality globally, with significant healthcare implications. Traditional risk assessment tools often fail to capture complex interactions among risk factors, leading to delayed diagnoses and suboptimal management. Machine learning offers a promising approach to enhance predictive accuracy and clinical applicability in CHD risk stratification.

Data Highlights

Validation TypeAUCAccuracyF1 Score
Internal0.9770.9420.944
External0.9290.885N/A

Key Findings

  • The model achieved an AUC of 0.977 in internal validation and 0.929 in external validation.
  • Accuracy rates were 94.2% for internal validation and 88.5% for external validation.
  • Key predictors identified included systolic blood pressure, age, total cholesterol, and fasting glucose.
  • SHAP analysis revealed nonlinear effects and interactions among predictors.
  • The model utilized a stacked ensemble approach combining gradient boosting, random forest, and XGBoost.

Clinical Implications

The validated machine learning model provides a robust tool for clinicians to assess CHD risk using readily available clinical metrics. Its strong performance in diverse cohorts suggests it could enhance early detection and management strategies for cardiovascular disease.

Conclusion

This study presents a machine learning model that effectively predicts CHD risk, demonstrating both high accuracy and generalizability. Such models could significantly improve cardiovascular risk assessment in clinical practice.

References

  1. European Journal of Preventive Cardiology, 2024 -- External validation and comparison of six cardiovascular risk prediction models in the Prospective Urban Rural Epidemiology (PURE)-Colombia study
  2. European Journal of Preventive Cardiology, 2024 -- Can Positive Psychosocial Factors Enhance Coronary Artery Disease Prediction? Insights from a Machine Learning Study Using UK Biobank Data
  3. European Journal of Preventive Cardiology, 2024 -- Creation and assessment of the CARE-DM model for forecasting cardiovascular risk in elderly individuals with type 2 diabetes
  4. European Journal of Preventive Cardiology, 2024 -- External validation of the 2023 American Heart Association Predicting Risk of cardiovascular disease EVENTs equations
  5. Development and Validation of AHA’s PREVENT Equations - American College of Cardiology, 2024
  6. Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patients - PubMed
  7. Machine learning based prediction models for cardiovascular disease risk using electronic health records data: systematic review and meta-analysis - PMC
  8. Development and Validation of AHA’s PREVENT Equations - American College of Cardiology
  9. Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patients - PubMed
  10. Machine learning based prediction models for cardiovascular disease risk using electronic health records data: systematic review and meta-analysis - PMC

Original Source(s)

Related Content